Generation and Genetic Correction of USH2A c.2299delG Mutation in Patient-Derived Induced Pluripotent Stem Cells
Open Access
Abstract
Usher syndrome (USH) is the leading cause of inherited combined hearing and vision loss. As an autosomal recessive trait, it affects 15,000 people in the United States alone and is responsible for ~21% of inherited blindness and 3 to 6% of early childhood deafness. Approximately 2/3 of the patients with Usher syndrome suffer from USH2, of whom 85% have mutations in the USH2A gene. Patients affected by USH2 suffer from congenital bilateral progressive sensorineural hearing loss and retinitis pigmentosa which leads to progressive loss of vision. To study the molecular mechanisms of this disease and develop a gene therapy strategy, we generated human induced pluripotent stem cells (iPSCs) from peripheral blood mononuclear cells (PBMCs) obtained from a patient carrying compound heterozygous variants of USH2A c.2299delG and c.1256G>T and the patient’s healthy sibling. The pluripotency and stability were confirmed by pluripotency cell specific marker expression and molecular karyotyping. Subsequent CRISPR/Cas9 genome editing using a homology repair template was used to successfully correct the USH2A c.2299delG mutation back to normal c.2299G in the generated patient iPSCs to create an isogenic pair of lines. Importantly, this manuscript describes the first use of the recombinant Cas9 and synthetic gRNA ribonucleoprotein complex approach to correct the USH2A c.2299delG without additional genetic effects in patient-derived iPSCs, an approach that is amenable for therapeutic genome editing. This work lays a solid foundation for future ex vivo and in vivo gene therapy investigations and these patient’s iPSCs also provide an unlimited resource for disease modeling and mechanistic studies.Keywords
Funding Information
- National Institute of Education (R01EY026521, R21EY030198,EY014800)
- National Institute on Deafness and Other Communication Disorders (R01DC005575,R01DC012115 , R01 DC016875)
- National Institute of Development Administration (R03 DA048704)
This publication has 48 references indexed in Scilit:
- Usher syndrome: Hearing loss, retinal degeneration and associated abnormalitiesBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2015
- Genetics and pathological mechanisms of Usher syndromeJournal of Human Genetics, 2010
- Mutation analysis in the long isoform of USH2A in American patients with Usher Syndrome type IIJournal of Human Genetics, 2009
- Genetic analysis of 2299delG and C759F mutations (USH2A) in patients with visual and/or auditory impairmentsEuropean Journal of Human Genetics, 2004
- Mutational spectrum in Usher syndrome type IIClinical Genetics, 2004
- A Common Ancestral Origin of the Frequent and Widespread 2299delG USH2A MutationThe American Journal of Human Genetics, 2001
- Spectrum of Mutations in USH2A in British Patients with Usher Syndrome Type IIExperimental Eye Research, 2001
- Genomic Structure and Identification of Novel Mutations in Usherin, the Gene Responsible for Usher Syndrome Type IIaThe American Journal of Human Genetics, 2000
- A Mutation (2314delG) in the Usher Syndrome Type IIA Gene: High Prevalence and Phenotypic VariationThe American Journal of Human Genetics, 1999
- Genetic heterogeneity of Usher syndrome type II in a Dutch population.Journal of Medical Genetics, 1996